240 likes | 353 Views
Good Morning!. Thursday, February 2, 2011. CSF Shunts. Used in the setting of hydrocephalus to divert CSF to another part of the body for absorption Proximal portion is placed in one of the cerebral ventricles Distal portion can be internalized or externalized VP- ventriculoperitoneal
E N D
Good Morning! Thursday, February 2, 2011
CSF Shunts • Used in the setting of hydrocephalus to divert CSF to another part of the body for absorption • Proximal portion is placed in one of the cerebral ventricles • Distal portion can be internalized or externalized • VP- ventriculoperitoneal • VA- ventriculoatrial
Shunt Infection • Rate of infection is 5 to 15% • Highest rates of infection • Initial month after placement • Patients requiring several revisions • Patients undergoing revision after treatment of infected shunt
Microbiology and Pathogenesis • Most commonly via colonization with skin flora • Occurs at time of surgery or post-op via breakdown of the wound or overlying skin • Most predominant pathogen • Staphylococci • 50% are coag-negative Staph • 30% are Staph aureus • Direct contamination of distal end of shunt • Bowel perforation or peritonitis • Variety of organisms: streptococci, gram-negative bacteria (including Pseudomonas), anaerobes, mycobacteria, and fungi • Hematongenous seeding
Clinical Manifestations • Can present with few or no symptoms • Sometimes symptoms only develop when shunt obstruction and malfuntion occurs • Clinical signs of increased intracranial pressure • Headache • Nausea/vomiting • Lethargy • Mental status changes • Meningeal signs may not be observed • Fever +/-
Clinical Manifestations • Symptoms may localize to distal or internal end of shunt • VP • Peritonitis (fever, abdominal pain, anorexia) • VA • Fever, bacteremia • Subsequent endocarditis
Diagnosis • CSF • Direct aspiration of the shunt is preferred • WBC count and diff, glucose, protein, Gram stain, culture • Results can be challenging • Less inflammation than bacterial meningitis • Cell count abnormalities may be subtle • White cell diff can be useful • >10% neutrophils has 90% sensitivity for predicitng infection • Culture results are critical for organism indentification and directing antibiotic therapy
Diagnosis (cont’d) • Blood cultures • Should be obtained • Higher yield in VA shunts • Imaging • To look for evidence of ventriculitis or CSF obstruction • Abdominal imaging may be useful to identify loculations at the distal end of VP shunts • CT or ultrasound
Treatment • 1) Removal of the device • If not feasible, intraventricular antibiotics • 2) External drainage • 3) Parenteral antibiotics • 4) Shunt replacement once CSF is sterile
Antibiotic Therapy • Guided by CSF gram stain and culture • Empiric therapy • Vancomycin + gram-negative coverage • For kids, cefotaxime • Intraventricular antibiotics • No controlled trials • Potentially toxic • Most experience with Vanc and Gent
Candida • Shunt infection usually occurs within several months of the surgical procedure • Results from implantation rather than hematogenous seeding • Most patients had received antibiotics, had previous bacterial meningitis, or had abdominal complications (intestinal perforation) • Symptoms and signs similar to bacterial shunt infection • Fever and shunt malfunction • Incidence is up to 17% in one study • Clinical manifestations are subtle and slowly progressive
Candida • Yeasts that reproduce by budding • Non-albicansCandida species now account for more than half of invasive infections • Candida parapsilosis can cause serious infections, especially in immunocompromised and debilitated hosts
Treatment of Candida CNS Infection • First line therapy • Amphotericin B • Lipid formulation achieves higher concentrations in the brain • +/- Flucytosine • *Side effects • Fluconazole • Excellent CNS penetration, however treatment outcomes vary • Use as step down treatment • Voriconazole • Excellent CSF concentrations • Limited clinical experience
Treatment of Candida CNS Infection (cont’d) • Posaconazole • Does NOT achieve adequate CSF levels • Echinocandins (caspofungin, micafungin, anidulafungin) • Do NOT achieve adequate CSF concentrations
Antibiotic Duration • No controlled trials to determine optimal duration • Suggested approach (UpToDate): • 1) If device removed, CSF chemistries are normal, and culture is positive for coag-negative staph → shunt may be replaced on 3rd day after removal if culture is negative • 2) Coag-negative staph and abnormal CSF chemistries → antibiotics for total time device remains in place and for 1 additional week following removal. CSF should be sterile prior to replacement
Antibiotic Duration (cont’d) • 3) Shunt infections with more virulent pathogens (S. aureus, gram-negative, etc) warrant at least 10 days (14 to 21 for gram-negative). CSF should be sterile for 10 days prior to shunt replacement • 4) If device is not removed, antibiotics for 7 to 10 days after sterilization of CSF
Prevention • Careful adherence to sterile technique • Antibiotic prophylaxis • Warranted in the intial 24 hours after device placement • Vancomycin is drug of choice due to predominant role of coag-negative staph • Antibiotic-impregnated catheters • Prophylactic catheter exchange • Not effective for preventing infection
Noon Conference Male GU, Dr. Nass